164 related articles for article (PubMed ID: 32007408)
1. Length of Stay Predicts Risk of Early Infection for Hospitalized Patients Undergoing Central Venous Port Placement.
Tang L; Kim CY; Martin JG; Pabon-Ramos WM; Sag AA; Suhocki PV; Smith TP; Ronald J
J Vasc Interv Radiol; 2020 Mar; 31(3):454-461. PubMed ID: 32007408
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Early Port Infections in Adult Oncologic Patients.
Skummer P; Kobayashi K; DeRaddo JS; Blackburn T; Schoeneck M; Patel J; Jawed M
J Vasc Interv Radiol; 2020 Sep; 31(9):1427-1436. PubMed ID: 32792279
[TBL] [Abstract][Full Text] [Related]
3. Clinical Predictors of Port Infections in Adult Patients with Hematologic Malignancies.
Zhang S; Kobayashi K; Faridnia M; Skummer P; Zhang D; Karmel MI
J Vasc Interv Radiol; 2018 Aug; 29(8):1148-1155. PubMed ID: 29960670
[TBL] [Abstract][Full Text] [Related]
4. Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement.
Pandey N; Chittams JL; Trerotola SO
J Vasc Interv Radiol; 2013 Jun; 24(6):849-54. PubMed ID: 23582442
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
[TBL] [Abstract][Full Text] [Related]
6. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center.
Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC
J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702
[TBL] [Abstract][Full Text] [Related]
7. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of PICC complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy.
Valbousquet Schneider L; Duron S; Arnaud FX; Bousquet A; Kervella Y; Bouzad C; Baccialone J; A'Teriitehau C; Potet J
J Vasc Access; 2015; 16(4):299-308. PubMed ID: 25953205
[TBL] [Abstract][Full Text] [Related]
9. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
10. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
Jo JE; Tang EY; Pua BB
Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
[TBL] [Abstract][Full Text] [Related]
11. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of radiologically implanted central venous port systems explanted due to complications.
Teichgräber UK; Kausche S; Nagel SN
J Vasc Access; 2011; 12(4):306-12. PubMed ID: 21534232
[TBL] [Abstract][Full Text] [Related]
13. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.
Berardi R; Rinaldi S; Santini D; Vincenzi B; Giampieri R; Maccaroni E; Marcucci F; Francoletti M; Onofri A; Lucarelli A; Pierantoni C; Tonini G; Cascinu S
Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients.
Zerati AE; Figueredo TR; de Moraes RD; da Cruz AM; da Motta-Leal Filho JM; Freire MP; Wolosker N; de Luccia N
J Vasc Surg Venous Lymphat Disord; 2016 Apr; 4(2):200-5. PubMed ID: 26993868
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Complication Rates of Central Venous Catheters Versus Peripherally Inserted Central Venous Catheters in Pediatric Patients.
Noonan PJ; Hanson SJ; Simpson PM; Dasgupta M; Petersen TL
Pediatr Crit Care Med; 2018 Dec; 19(12):1097-1105. PubMed ID: 30142121
[TBL] [Abstract][Full Text] [Related]
16. Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kang EY; Yong HS; Seo JH; Choi YY
J Vasc Access; 2015; 16(4):315-20. PubMed ID: 25953212
[TBL] [Abstract][Full Text] [Related]
17. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of catheter infection rates in converted dialysis catheters versus de novo placement in the setting of chlorhexidine use.
Criddle JM; Hieb RA; White SB; Patel PJ; Hohenwalter EJ; Tutton SM; Rilling WS
J Vasc Access; 2016; 17(2):162-6. PubMed ID: 26660045
[TBL] [Abstract][Full Text] [Related]
19. Image-guided placement of port catheters: is there an increased risk of infection if the port is immediately accessed and used?
Salazar G; Yeddula K; Wicky S; Oklu R; Ganguli S; Waltman AC; Walker TG; Kalva SP
J Vasc Access; 2013; 14(2):170-4. PubMed ID: 23080333
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
